United States · FDA National Drug Code directory
Heparin Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-459_529104c9-6154-4428-953d-5546875f32e5
- Product NDC
- 63323-459
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HEPARIN SODIUM
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 19720222
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPARIN SODIUM — 10000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →